Travere Therapeutics said Tuesday it plans to ask the FDA for approval of its kidney drug Filspari in a rare condition known ...
Biohaven lands priority review on second-chance application for neurodegenerative drug
FDA grants priority review for Biohaven's troriluzole for spinocerebellar ataxia after real-world data submission. Decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback